查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266328

心室輔助裝置市場：按產品、應用、設計、年齡分類：2021-2031 年全球機遇分析和行業預測

Ventricular Assist Devices Market By Product, By Application, By Design, By Age : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 316 Pages | 商品交期: 2-3個工作天內

價格

2021 年心室輔助裝置市場價值為 133853 萬美元，預計到 2031 年將達到 288066 萬美元，2022 年至 2031 年的複合年增長率為 7.9%。

心室輔助裝置 (VAD)，也稱為機械循環支持 (MCS) 裝置，支持心臟的泵血功能。 它用於增加流經患者身體的血量。 這使得晚期心力衰竭患者的生活質量再次得到改善。 心室輔助裝置支持右心室或左心室，但大多數放置在左心室中。 當放置在左心室時，它被稱為左心室輔助裝置 (LVAD)。

心室輔助裝置常用於治療心力衰竭。 VAD 移植可以是臨時的或永久的，具體取決於移植的功能。 在患者等待心臟移植或接受治療以幫助心臟恢復直至健康到可以自行泵血之前，會進行臨時心臟移植。

另一方面，對心室功能異常的患者進行永久植入，以確保足夠的血液流經心臟。 這種在心力衰竭治療中的應用增加了醫療領域對心室輔助裝置的需求，推動了市場增長。 此外，患者和醫療保健專業人員對心室輔助裝置認識的提高正在推動市場增長。

此外，政府和其他團體正在努力提高公眾對心血管疾病及其先進療法的認識。 例如，英國國民健康服務體系（NHS）的長期計劃是通過初級保健網絡（PCNs）促進社區心力衰竭的早期發現，加強多學科團隊（MDT）主導的護理，並專注於醫院的專科護理. 將心力衰竭作為 2019 年的優先事項。 各種組織開展的提高認識工作也提高了公眾對心力衰竭先進治療方法（包括心室輔助裝置）的認識。 這進一步導致了心室輔助裝置市場的擴大。

各種因素正在推動市場增長，但與心室輔助裝置相關的高成本和與手術相關的重大風險阻礙了市場增長。 這些高價格限制了主要在發展中國家和不發達國家獲得心室輔助裝置的機會。 此外，欠發達國家的人們對先進的心力衰竭治療缺乏認識，也制約了市場的增長。 此外，心室輔助裝置的植入在手術過程中會因血塊和出血而導致感染和裝置故障，這也是市場的製約因素。

與此同時，主要市場參與者正在大力投資與心室輔助裝置相關的研發活動。 公司正專注於創新以開發先進的心室輔助裝置，以克服現有心室輔助裝置的缺點。 此外，正在進行大量臨床試驗和開發研究，以證明心室輔助裝置的效率並獲得批准。 預計這將在預測期內推動市場擴張。

例如，2022 年 10 月，Abiomed 獲得了美國食品和藥物管理局 (FDA) 的上市前批准 (PMA)，用於使用 SmartAssist 的 Impella RP Flex 可安全有效地治療長達 14 天的急性右心衰竭。)宣布已收購 此類產品的批准和推出正在促進市場的增長。 此外，全球心力衰竭的激增、心室輔助裝置的新技術進步、患者對心臟監測的認識、心臟捐獻者短缺等都在推動市場的增長。

心室輔助裝置市場按產品、應用、設計、年齡和地區劃分。 按產品分為左心室輔助裝置（LVAD）、右心室輔助裝置（RVAD）和雙心室輔助裝置（BIVAD）。 按應用又分為移植橋（BTT）、靶向治療、恢復橋（BTR）和靶向治療橋。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭激烈程度
  • 市場動態
    • 司機
      • 心力衰竭的發生率增加
      • 技術進步
      • 提高了患者對心力衰竭治療方案的認識
      • 心臟捐獻者短缺
    • 約束因素
      • 設備和程序成本高
      • 與程序相關的重大風險
    • 機會
      • 新興市場的有利機會
  • 分析 COVID-19 對市場的影響

第 4 章心室輔助裝置市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 左心室輔助裝置 (LVAD)
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 右心室輔助裝置 (RVAD)
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 雙腔輔助裝置 (BIVAD)
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章心室輔助裝置市場：按應用

  • 概覽
    • 市場規模和預測
  • 移植橋 (BTT)
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 目的地療法
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 恢復之橋 (BTR)
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 候選療法的橋樑
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章心室輔助裝置市場：按設計

  • 概覽
    • 市場規模和預測
  • 經皮心室輔助裝置
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 植入式心室輔助裝置
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章心室輔助裝置市場：按年齡分類

  • 概覽
    • 市場規模和預測
  • 成人
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 兒科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 8 章。心室輔助裝置市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 市場規模和設計預測
    • 市場規模和預測：按年齡段
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
  • 歐洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 市場規模和設計預測
    • 市場規模和預測：按年齡段
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
  • 亞太地區
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 市場規模和設計預測
    • 市場規模和預測：按年齡段
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 市場規模和預測：按產品
    • 市場規模和應用預測
    • 市場規模和設計預測
    • 市場規模和預測：按年齡段
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段
      • 拉丁美洲其他地區/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按產品
      • 市場規模和應用預測
      • 市場規模和設計預測
      • 市場規模和預測：按年齡段

第9章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2021 年

第十章公司簡介

  • Evaheart, Inc.
  • Calon Cardio-Technology Ltd
  • Carmat SA
  • Fineheart
  • AdjuCor GmbH
  • Corewave SA
  • Bivacor Inc.
  • Windmill Cardiovascular Systems
  • NuPulseCV, Inc.
  • Abiomed, Inc.
  • LivaNova PLC
  • Berlin Heart GmbH
  • Jarvik Heart, Inc.
  • Abbott Laboratories
  • SynCardia Systems, LLC
  • CH Biomedical, Inc.
Product Code: A01694

The ventricular assist devices market valued for $1,338.53 million in 2021 and is estimated to reach $2,880.66 million by 2031, exhibiting a CAGR of 7.9% from 2022 to 2031.  

Ventricular assist device (VAD), also known as mechanical circulatory support (MCS) device, supports the pumping function of the heart. It is used to increase the amount of blood that flows through the patient's body. It enables a patient with advanced heart failure to lead an improved quality of life once again. A ventricular assist device (VAD) helps in supporting either of the right or the left ventricle, however, is mostly implanted in the left ventricle. When placed in the left ventricle, it is called a left ventricular assist device (LVAD).  

Ventricular assist devices are commonly used in treatment of heart failure. The VAD transplant can be temporary or permanent depending on the function for which it is implanted. They are implanted temporarily when the patient is either waiting for a heart transplant or is receiving treatment to help the heart recover until it is healthy enough to pump blood on its own.  

On the other hand, it is implanted permanently to ensure proper blood flow through the heart in the patient with abnormal ventricle function. Such applications of ventricular assist devices in treatment of heart failure increases its demand in the healthcare sector and thus boost the growth of the market. In addition, rise in awareness among the patients and healthcare practitioners about ventricular assist devices fosters the market growth.  

Moreover, there are initiatives taken up by the governments and other organizations in creating awareness among the people regarding cardiovascular diseases and its advanced treatment options. For instance, the National Health Service (NHS) Long Term Plan for England designated heart failure as a priority in 2019, with a focus on promoting earlier detection of heart failure in the community through primary care networks (PCNs), a stronger emphasis on multidisciplinary teams (MDT)-led care, and quicker access to specialized care in hospitals. Such awareness programs initiated by various organizations increase the public awareness about advanced treatment options in heart failure including the ventricular assist devices. This further leads to the expansion of the ventricular assist devices market. 

Although, various key factors are driving the growth of the market, there are few factors such as high cost associated with the device & implantation and serious risks involved in the procedure are hampering the growth of the market. These high prices create limitations in accessing ventricular assist devices majorly in developing and underdeveloped countries. Moreover, lack of awareness about advanced treatment procedures for heart failure among the people in underdeveloped countries also acts as a restraint to the growth of the market. In addition, implanting a VAD may result in blood clots and bleeding from the surgery that may cause infection and device malfunction, which act as a restraint to the market. 

On the other hand, the key market players are investing on a large scale for the R&D activities related to ventricular assist devices. Companies are focusing on innovation to develop advanced ventricular assist devices that can overcome the drawbacks of the existing VADs. Moreover, large number of clinical and developmental studies are carried out to prove the efficiency of the devices, and to get the approval for the same. This is anticipated to drive the market expansion during the forecast period.  

For instance, in October 2022, Abiomed announced that Impella RP Flex with SmartAssist received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), as safe and effective to treat acute right heart failure for up to 14 days. Thus, more such product approvals and launches contribute to the growth of the market. Moreover, surge in incidences of heart failure across the globe, new technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and shortage of heart donors drive the market growth.  

The ventricular assist devices market is segmented on the basis of product, application, design, age, and region. By product, the market is categorized into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). On the basis of application, the market is fragmented into bridge-to-transplant (BTT), destination therapy, bridge-to-recovery (BTR), and bridge to candidacy therapy.  

On the basis of design, the market is bifurcated into transcutaneous ventricular assist devices and implantable ventricular assist devices. By age, the market is divided into adults and pediatrics. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major Key players that operate in the global ventricular assist devices market are: Abbott Laboratories, Abiomed, Inc., AdjuCor GmbH, Berlin Heart GmbH, Bivacor Inc., Calon Cardio-Technology Ltd, Carmat SA, CH Biomedical, Inc., Corewave SA, Evaheart, Inc., Fineheart, Jarvik Heart, Inc., LivaNova PLC, NuPulseCV, Inc., SynCardia Systems, LLC, and Windmill Cardiovascular Systems.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ventricular assist devices market analysis from 2021 to 2031 to identify the prevailing ventricular assist devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ventricular assist devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ventricular assist devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)

By Application

  • Bridge-To-Transplant (BTT)
  • Destination Therapy
  • Bridge-To-Recovery (BTR)
  • Bridge To Candidacy Therapy

By Design

  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices

By Age

  • Adults
  • Pediatrics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Evaheart, Inc.
  • Abiomed, Inc.
  • Abbott Laboratories
  • CH Biomedical, Inc.
  • Carmat SA
  • Calon Cardio-Technology Ltd
  • Bivacor Inc.
  • LivaNova PLC
  • Berlin Heart GmbH
  • Fineheart
  • AdjuCor GmbH
  • NuPulseCV, Inc.
  • Jarvik Heart, Inc.
  • SynCardia Systems, LLC
  • Corewave SA
  • Windmill Cardiovascular Systems

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in incidence of heart failures
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Rise in patient awareness about heart failure treatment options
      • 3.4.1.4. Dearth of heart donors
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of devices and procedures
      • 3.4.2.2. Serious risks involved in the procedure
    • 3.4.3. Opportunities
      • 3.4.3.1. Lucrative opportunities in the emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Left Ventricular Assist Devices (LVADs)
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Right Ventricular Assist Devices (RVADs)
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Biventricular Assist Devices (BIVADs)
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Bridge-To-Transplant (BTT)
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Destination Therapy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Bridge-To-Recovery (BTR)
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Bridge To Candidacy Therapy
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Transcutaneous Ventricular Assist Devices
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Implantable Ventricular Assist Devices
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Adults
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Pediatrics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Product
    • 8.2.3. Market size and forecast, by Application
    • 8.2.4. Market size and forecast, by Design
    • 8.2.5. Market size and forecast, by Age
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Product
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by Design
      • 8.2.6.1.5. Market size and forecast, by Age
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Product
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by Design
      • 8.2.6.2.5. Market size and forecast, by Age
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Product
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by Design
      • 8.2.6.3.5. Market size and forecast, by Age
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Product
    • 8.3.3. Market size and forecast, by Application
    • 8.3.4. Market size and forecast, by Design
    • 8.3.5. Market size and forecast, by Age
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Product
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by Design
      • 8.3.6.1.5. Market size and forecast, by Age
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Product
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by Design
      • 8.3.6.2.5. Market size and forecast, by Age
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Product
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by Design
      • 8.3.6.3.5. Market size and forecast, by Age
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Product
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by Design
      • 8.3.6.4.5. Market size and forecast, by Age
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Product
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by Design
      • 8.3.6.5.5. Market size and forecast, by Age
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Product
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by Design
      • 8.3.6.6.5. Market size and forecast, by Age
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Product
    • 8.4.3. Market size and forecast, by Application
    • 8.4.4. Market size and forecast, by Design
    • 8.4.5. Market size and forecast, by Age
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Product
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by Design
      • 8.4.6.1.5. Market size and forecast, by Age
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Product
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by Design
      • 8.4.6.2.5. Market size and forecast, by Age
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Product
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by Design
      • 8.4.6.3.5. Market size and forecast, by Age
      • 8.4.6.4. India
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Product
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by Design
      • 8.4.6.4.5. Market size and forecast, by Age
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Product
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by Design
      • 8.4.6.5.5. Market size and forecast, by Age
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Product
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by Design
      • 8.4.6.6.5. Market size and forecast, by Age
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Product
    • 8.5.3. Market size and forecast, by Application
    • 8.5.4. Market size and forecast, by Design
    • 8.5.5. Market size and forecast, by Age
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Product
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by Design
      • 8.5.6.1.5. Market size and forecast, by Age
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Product
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by Design
      • 8.5.6.2.5. Market size and forecast, by Age
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Product
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by Design
      • 8.5.6.3.5. Market size and forecast, by Age
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Product
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by Design
      • 8.5.6.4.5. Market size and forecast, by Age

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Evaheart, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Key strategic moves and developments
  • 10.2. Calon Cardio-Technology Ltd
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
  • 10.3. Carmat SA
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Fineheart
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. AdjuCor GmbH
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Corewave SA
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Key strategic moves and developments
  • 10.7. Bivacor Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Key strategic moves and developments
  • 10.8. Windmill Cardiovascular Systems
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. NuPulseCV, Inc.
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. Abiomed, Inc.
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments
  • 10.11. LivaNova PLC
    • 10.11.1. Company overview
    • 10.11.2. Key Executives
    • 10.11.3. Company snapshot
    • 10.11.4. Operating business segments
    • 10.11.5. Product portfolio
    • 10.11.6. Business performance
    • 10.11.7. Key strategic moves and developments
  • 10.12. Berlin Heart GmbH
    • 10.12.1. Company overview
    • 10.12.2. Key Executives
    • 10.12.3. Company snapshot
    • 10.12.4. Operating business segments
    • 10.12.5. Product portfolio
    • 10.12.6. Key strategic moves and developments
  • 10.13. Jarvik Heart, Inc.
    • 10.13.1. Company overview
    • 10.13.2. Key Executives
    • 10.13.3. Company snapshot
    • 10.13.4. Operating business segments
    • 10.13.5. Product portfolio
  • 10.14. Abbott Laboratories
    • 10.14.1. Company overview
    • 10.14.2. Key Executives
    • 10.14.3. Company snapshot
    • 10.14.4. Operating business segments
    • 10.14.5. Product portfolio
    • 10.14.6. Business performance
    • 10.14.7. Key strategic moves and developments
  • 10.15. SynCardia Systems, LLC
    • 10.15.1. Company overview
    • 10.15.2. Key Executives
    • 10.15.3. Company snapshot
    • 10.15.4. Operating business segments
    • 10.15.5. Product portfolio
    • 10.15.6. Key strategic moves and developments
  • 10.16. CH Biomedical, Inc.
    • 10.16.1. Company overview
    • 10.16.2. Key Executives
    • 10.16.3. Company snapshot
    • 10.16.4. Operating business segments
    • 10.16.5. Product portfolio
    • 10.16.6. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
  • TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
  • TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
  • TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
  • TABLE 117. EVAHEART, INC.: KEY STRATERGIES
  • TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
  • TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
  • TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
  • TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
  • TABLE 122. CARMAT SA: KEY EXECUTIVES
  • TABLE 123. CARMAT SA: COMPANY SNAPSHOT
  • TABLE 124. CARMAT SA: PRODUCT SEGMENTS
  • TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
  • TABLE 126. CARMAT SA: KEY STRATERGIES
  • TABLE 127. FINEHEART: KEY EXECUTIVES
  • TABLE 128. FINEHEART: COMPANY SNAPSHOT
  • TABLE 129. FINEHEART: PRODUCT SEGMENTS
  • TABLE 130. FINEHEART: PRODUCT PORTFOLIO
  • TABLE 131. FINEHEART: KEY STRATERGIES
  • TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
  • TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
  • TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
  • TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
  • TABLE 136. COREWAVE SA: KEY EXECUTIVES
  • TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
  • TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
  • TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
  • TABLE 140. COREWAVE SA: KEY STRATERGIES
  • TABLE 141. BIVACOR INC.: KEY EXECUTIVES
  • TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
  • TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
  • TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
  • TABLE 145. BIVACOR INC.: KEY STRATERGIES
  • TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
  • TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
  • TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
  • TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
  • TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
  • TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
  • TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
  • TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
  • TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
  • TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
  • TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
  • TABLE 158. ABIOMED, INC.: KEY STRATERGIES
  • TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
  • TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
  • TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 163. LIVANOVA PLC: KEY STRATERGIES
  • TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
  • TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
  • TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
  • TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
  • TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
  • TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
  • TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
  • TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
  • TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
  • TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
  • TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
  • TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
  • TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
  • TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
  • TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
  • TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN VENTRICULAR ASSIST DEVICES MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALVENTRICULAR ASSIST DEVICES MARKET
  • FIGURE 10. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 14. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY COUNTRY 2021-2031(%)
  • FIGURE 19. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
  • FIGURE 22. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY COUNTRY 2021-2031(%)
  • FIGURE 25. VENTRICULAR ASSIST DEVICES MARKET BY REGION, 2021
  • FIGURE 26. U.S. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. MEXICO VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. GERMANY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. FRANCE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. ITALY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. JAPAN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: VENTRICULAR ASSIST DEVICES MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2021
  • FIGURE 52. ABIOMED, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. ABIOMED, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)